{
    "nctId": "NCT00500500",
    "officialTitle": "Effect of EGb 761\u00ae on the Ratio of the Isoforms of the Protein Precursor of Beta Amyloid Platelets on Patients With Mild to Moderate Alzheimer's Disease. A Phase II, Randomised, Double-blind Trial, on Parallel Groups Versus Placebo.",
    "inclusionCriteria": "* female or male of 50 to 85 years old with a care giver\n* Mini Mental Status (MMS) test between 16 to 26 inclusive\n* Clinical Dementia Rating (CDR) test inferior or equal to 1\n* National Institute of Neurological and Communicative Disorders and Stroke / Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) test positive for an Alzheimer's disease\n* Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM IV) test positive for dementia\n* Must have minimum age of 50 Years\n* Must have maximum age of 85 Years",
    "exclusionCriteria": "* patient already treated by medicines which could interfere with the study\n* low level of vitamin B12 and folate which are considered as clinically relevant\n* clinically relevant pathologies (eg: pulmonary illness, cardiovascular illness; evolutive cancer, neurological illness, blood illness....)"
}